Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
SYNJ1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FKBP1A-SDCBP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TLL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KLF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GALNT16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARL17B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
NAA15 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF138 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101930349 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PDE7B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CH17-408M7.1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRVI1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HOGA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ESAM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RALGAPA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMAD4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IL1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on